How To Approach “Extraordinarily Risky” Clinical-Stage Biotech Stocks
“Investing in any kind of stock can be risky. But investing in clinical-stage biotech stocks can be extraordinarily risky,” acknowledge the authors of today’s article.…
davidgoldstein
Wall Street Is “Pounding The Table” On This Sector – 5 Picks For Aggressive Investors
“With West Texas Intermediate (WTI) crude trading near the $60 a barrel level, and expected to go even higher this summer, these could all have…
A Stock Screen For Superior Returns With Earnings Yield At The Core
In screening for stocks with the potential of generating solid returns, the author of today’s article uses a high earnings yield as their primary criterion,…
A Focus On Next-Generation Brain Surgery Could Make This Stock A No-Brainer
The company featured in today’s article is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain – and…
Don’t Run Scared From The Recent Sell-Off In Small And Micro-Cap Stocks – Pounce On It!
“Scared money runs and misses out on profits, while smart money is always poised to pounce on temporary disconnects,” declares the author of today’s article…
Real Potential In These Artificial Intelligence Stocks
“As corporate budgets start to thaw this year along with a gradually reopening economy, AI applications are expected to receive plenty of attention,” notes the…
A Recently Approved Label Expansion Could Expand This Pain Management Stock’s Horizons
Amid the ongoing opioid crisis, the need for non-opioid pain management solutions is increasing. As a provider of pre- and post-surgical non-opioid pain management solutions,…
Is This Biopharma Company With A Unique Business A Buy?
With a portfolio currently comprised of 45 commercial products and five developmental-stage candidates in various areas, including rare disease and neurology, the company featured in…
Profit From The “Urge To Merge” In The Diagnostics Space
On the heels of the news of Roche acquiring GenMark Diagnostics, the author of today’s article shares two more leading diagnostics companies that he believes are prime…
5 Stocks Under $10 Offering Solid Alpha Potential For Aggressive Investors
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…